PILR-alpha Antibody (2175B) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # FAB64842F
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Neutralization
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 2175B
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human PILR‑ alpha with a C-terminal 6-His tag
Gln20-Thr196
Accession # Q9UKJ1
Gln20-Thr196
Accession # Q9UKJ1
Specificity
Detects human PILR‑ alpha in direct ELISAs.
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for PILR-alpha Antibody (2175B) [FITC]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Neutralization
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from cell culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PILR-alpha
Long Name
Paired-Ig-likeType 2 Receptor alpha
Alternate Names
FDF03, PILRA, PILRalpha
Additional PILR-alpha Products
Product Documents for PILR-alpha Antibody (2175B) [FITC]
Product Specific Notices for PILR-alpha Antibody (2175B) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...